|
|
|
|
|
Potential drivers of reduced AMI rates
|
|
|
|
What about revascularisation?
|
|
|
|
Summary 1.
|
|
|
|
Life Saving Strategies in AMI
|
|
|
|
33% of people who die from AMI do so before they reach hospital
|
|
|
|
|
BHF Doubt Kills Campaign
|
|
|
|
Summary 2.
|
|
|
|
Life Saving Strategies in AMI
|
|
|
|
STEMI: reperfusion therapy
|
|
|
|
Impact of door to balloon time
|
|
|
|
Culprit only vs complete revascularisation in STEMI:
|
|
|
|
DES vs BMS for primary PCI:
|
|
|
|
Dual antiplatelet therapy (DAPT) - continue for 12 months after DES
|
|
|
|
New Inhibitors of the platelet the ADP P2Y12 receptor
|
|
|
|
PLATO: ticagrelor vs clopidogrel in ACS
|
|
|
|
|
|
NSTEMI: emergency treatment
|
|
|
|
NSTEMI: don’t under-estimate it
|
|
|
|
Trials of Invasive vs Conservative Treatment Strategy in NSTEMI
|
|
|
|
Routine Versus Selective Invasive Strategy in NSTEMI
|
|
|
|
Life Saving Strategies in AMI
|
|
|
|
Adjusted KM curves: 1 yr survival by number of 2° prevention drugs
|
|
|
|
Impact of under-utilisation:
|
|
|
|
GPRD: Continuing statin therapy in 12m post ACS
|
|
|
|
Discontinuation of clopidogrel(“non-compliance”) after discharge
|
|
|
|
Summary 4.
|
|
|
|
Life Saving Strategies in AMI
|
|
|
|
Implantable defibrillator post AMI
|
|
|
|
The revolution for coronary outcomes in east London
|
|
presentation (PPT 4.6MB)
Share this page with your colleagues and friends: